PRGO earnings date and last-quarter result: last quarter miss, P/E -0.80. Updated 2026-07-23.
Perrigo (PRGO) Research Hub
Perrigo (PRGO) trades on NYSE, IE in the Healthcare (Drug Manufacturers - Specialty & Generic) sector. As of 2026-10-26, shares last closed at 15.82 USD (-0.88%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.80, market cap 1.47B. This hub links to the full technical, earnings and options research available for PRGO.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Drug Manufacturers - Specialty & Generic) |
|---|---|
| Exchange | NYSE, IE |
| Last close | 15.82 USD (-0.88%) |
| 52-week range | 9.53 USD – 16.79 USD |
| Trend regime | Range |
| 14-day RSI | 69 (Bullish) |
| Trailing P/E | -0.80 |
| Market cap | 1.47B |
| Dividend yield | 11.08% |
Available research for PRGO
Covered Call on PRGO: how it works, illustrative setup around the real 15.82 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on PRGO: how it works, illustrative setup around the real 15.82 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on PRGO: how it works, illustrative setup around the real 15.82 USD price, max profit/loss, breakeven and when to use it. Educational.
PRGO technical analysis: range, last 15.82 USD, RSI 69, 52w range 9.53 USD–16.79 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is PRGO in?
Perrigo (PRGO) is classified under Healthcare (Drug Manufacturers - Specialty & Generic), listed on NYSE, IE.
Is PRGO in an uptrend or downtrend?
As of 2026-10-26, PRGO is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is PRGO's trailing P/E ratio?
PRGO's trailing P/E is -0.80, with a market cap of 1.47B. See the earnings research page for full valuation detail.